AR017217A1 - BISPIDINE ANTIARRITHMIC COMPOUNDS, PHARMACEUTICAL FORMULATION, USE OF THE SAME TO PREPARE MEDICINES, PROCESS TO PREPARE SUCH COMPOUNDS, INTERMEDIARY COMPOUNDS, AND PROCESS TO PREPARE THEM - Google Patents
BISPIDINE ANTIARRITHMIC COMPOUNDS, PHARMACEUTICAL FORMULATION, USE OF THE SAME TO PREPARE MEDICINES, PROCESS TO PREPARE SUCH COMPOUNDS, INTERMEDIARY COMPOUNDS, AND PROCESS TO PREPARE THEMInfo
- Publication number
- AR017217A1 AR017217A1 ARP980106399A ARP980106399A AR017217A1 AR 017217 A1 AR017217 A1 AR 017217A1 AR P980106399 A ARP980106399 A AR P980106399A AR P980106399 A ARP980106399 A AR P980106399A AR 017217 A1 AR017217 A1 AR 017217A1
- Authority
- AR
- Argentina
- Prior art keywords
- prepare
- compounds
- alkyl
- group
- independently represent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un compuesto que comprende la formula(I) en la cual R1 y R2 independientemente representan H, alquilo C1-4 o juntos forman -O-(CH2)2-O-, -(CH2)4 -o-(CH2)5R9 representa alquilo C1-12, fenilo, naftilo, alquilfenilo C1-3 (estando todos estos cuatro grupos optativamente sustituidos o terminados con uno o mássustituyentes seleccionados entre -OH, halo, ciano,nitro, alquilo C1-4 o alcoxi C1-4) o-(CH2)qCy1; R10 representa H o -OH; R11 representa H o alquilo C1-4, R12representa uno o más sustituyentes optativos seleccionados entre -OH, ciano, halo, amino, nitro, alquilo C1-6, alcoxi C1-6, -N(H)S(O)2R16, -OS(O)2R16a,N(H)C(O)N(H)R17 o -C(O)N(H)R18; A representaun enlace simple, alquileno C1-4, -(CH2)nN(R20), -(CH2)nS(O)p- -(CH2)NO- (estando elgrupo -(CH2)n- de estos tres ultimos grupos unido al átomo de carbono que contiene R10 y R11), -C(O)N(R20)- (estando el grupo -C(O) de éste ultimo grupo unidoal átomo de carbono que contiene R10 y R11), -N(R20)C(O)O(CH2)n-, -N(R20)(CH2)n- (en estos dos ultimos grupos, el grupo N(R20) está unido al átomo de carbonoque acarrea R10 y R11) o -(CH2)mC(H)(OH)(CH2)n- (es este ultimo grupo, el grupo -(CH2)m- está unido al átomo de carbono que acarrea R10 y R11); B representa unenlace simple, alquileno C1-6, -N(R23)(CH2)r - o -O(CH2)r (en estos dos ultimos grupos, el grupo -(CH2)r está unido al átomo de nitrogeno de la bispidina); mrepresenta 1, 2 o 3; n y r representan independientemente 0,1,2,3 o 4; p representa 0,1 o 2; q representa 0,1,2 o 3; X representa O o S; Cy1 representa unanillo heterocíclico de cinco a siete miembros que contiene uno o más heteroátomos seleccionados entre O, N o S, anillo que está optativamente sustituido conuno o más sustituyentes seleccionados entre C(O)R21 o C(O)OR22, R16, R16a, R20 y R23 representan independientemente H o alquilo C1-4 y R17, R18, R21 y R22representan independientemente H o alquilo C1-4 y R17, R18, R21 y R22 representan independientemente H o alquilo C1-6; o un derivado farmacéuticamenteA compound comprising the formula (I) in which R1 and R2 independently represent H, C1-4 alkyl or together form -O- (CH2) 2-O-, - (CH2) 4 -o- (CH2) 5R9 represents C1-12 alkyl, phenyl, naphthyl, C1-3 alkylphenyl (all four groups being optionally substituted or terminated with one or more substituents selected from -OH, halo, cyano, nitro, C1-4 alkyl or C1-4 alkoxy) or- (CH2) qCy1; R10 represents H or -OH; R11 represents H or C1-4 alkyl, R12 represents one or more optional substituents selected from -OH, cyano, halo, amino, nitro, C1-6 alkyl, C1-6 alkoxy, -N (H) S (O) 2R16, - OS (O) 2R16a, N (H) C (O) N (H) R17 or -C (O) N (H) R18; A represents a single bond, C1-4 alkylene, - (CH2) nN (R20), - (CH2) nS (O) p- - (CH2) NO- (the group being - (CH2) n- of these last three groups attached to the carbon atom containing R10 and R11), -C (O) N (R20) - (the group -C (O) of the latter being attached to the carbon atom containing R10 and R11), -N (R20) C (O) O (CH2) n-, -N (R20) (CH2) n- (in these last two groups, the group N (R20) is attached to the carbon atom that carries R10 and R11) or - (CH2) mC (H) (OH) (CH2) n- (is the latter group, the group - (CH2) m- is attached to the carbon atom that carries R10 and R11); B represents a simple bond, C1-6 alkylene, -N (R23) (CH2) r - or -O (CH2) r (in these last two groups, the group - (CH2) r is attached to the bispidine nitrogen atom ); mrepresenta 1, 2 or 3; n and r independently represent 0,1,2,3 or 4; p represents 0.1 or 2; q represents 0,1,2 or 3; X represents O or S; Cy1 represents a five to seven membered heterocyclic ring containing one or more heteroatoms selected from O, N or S, ring that is optionally substituted with one or more substituents selected from C (O) R21 or C (O) OR22, R16, R16a, R20 and R23 independently represent H or C1-4 alkyl and R17, R18, R21 and R22 independently represent H or C1-4 alkyl and R17, R18, R21 and R22 independently represent H or C1-6 alkyl; or a pharmaceutically derived
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704709A SE9704709D0 (en) | 1997-12-17 | 1997-12-17 | Pharmaceutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017217A1 true AR017217A1 (en) | 2001-08-22 |
Family
ID=20409426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106399A AR017217A1 (en) | 1997-12-17 | 1998-12-16 | BISPIDINE ANTIARRITHMIC COMPOUNDS, PHARMACEUTICAL FORMULATION, USE OF THE SAME TO PREPARE MEDICINES, PROCESS TO PREPARE SUCH COMPOUNDS, INTERMEDIARY COMPOUNDS, AND PROCESS TO PREPARE THEM |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6291475B1 (en) |
| EP (1) | EP1047695B1 (en) |
| JP (1) | JP2002508375A (en) |
| KR (1) | KR20010024723A (en) |
| CN (1) | CN1284956A (en) |
| AR (1) | AR017217A1 (en) |
| AT (1) | ATE261964T1 (en) |
| AU (1) | AU1795399A (en) |
| BR (1) | BR9813668A (en) |
| CA (1) | CA2314490A1 (en) |
| DE (1) | DE69822513T2 (en) |
| DK (1) | DK1047695T3 (en) |
| EE (1) | EE200000365A (en) |
| ES (1) | ES2216337T3 (en) |
| HU (1) | HUP0102307A3 (en) |
| ID (1) | ID24638A (en) |
| IL (1) | IL136374A0 (en) |
| IS (1) | IS5522A (en) |
| NO (1) | NO20003137L (en) |
| NZ (1) | NZ504909A (en) |
| PL (1) | PL341388A1 (en) |
| PT (1) | PT1047695E (en) |
| SE (1) | SE9704709D0 (en) |
| SI (1) | SI1047695T1 (en) |
| SK (1) | SK7812000A3 (en) |
| TR (1) | TR200001757T2 (en) |
| WO (1) | WO1999031100A1 (en) |
| ZA (1) | ZA9811130B (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9803517D0 (en) * | 1998-10-15 | 1998-10-15 | Astra Ab | Pharmaceutical preparation |
| TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| SE9902269D0 (en) * | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| SE9902270D0 (en) | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| SE9902271D0 (en) * | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| US20050004113A1 (en) * | 1999-06-16 | 2005-01-06 | Astrazeneca Ab | New bispidine compounds useful in the treatment of cardiac arrhythmias |
| US20040229900A1 (en) * | 1999-06-16 | 2004-11-18 | Astrazeneca Ab | Bispidine compounds useful in the treatment of cardiac arrythmias |
| SE9902268D0 (en) * | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| US7038054B1 (en) * | 1999-09-03 | 2006-05-02 | Pharmacopeia Drug Discovery, Inc. | Diazabicyclononane scaffold for combinatorial synthesis |
| SE9903759D0 (en) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| JP2003516988A (en) | 1999-12-14 | 2003-05-20 | ニューロサーチ、アクティーゼルスカブ | New heteroaryl-diazabicycloalkanes |
| SE9904765D0 (en) | 1999-12-23 | 1999-12-23 | Astra Ab | Pharmaceutically useful compounds |
| AR030302A1 (en) * | 2000-07-07 | 2003-08-20 | Astrazeneca Ab | BISPIDINE COMPOUNDS, PHARMACEUTICAL FORMULATION, USE FOR THE MANUFACTURE OF MEDICINES, PROCESS FOR THE PREPARATION OF THESE INTERMEDIATE COMPOUNDS AND COMPOUNDS |
| SE0002603D0 (en) * | 2000-07-07 | 2000-07-07 | Astrazeneca Ab | New compounds |
| US6808924B1 (en) | 2000-07-11 | 2004-10-26 | Claudia Lanari | Mouse mammary tumor lines expressing estrogen and progesterone receptors |
| AR030756A1 (en) | 2000-10-02 | 2003-09-03 | Astrazeneca Ab | COMPOUND OF OXABISPIDINE USEFUL IN THE TREATMENT OF CARDIAC ARRITMIES |
| SE0003795D0 (en) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Pharmaceutically useful compounds |
| SE0100326D0 (en) | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
| SE0101329D0 (en) * | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Pharmaceutical formulation |
| SE0101324D0 (en) * | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New process |
| SE0101327D0 (en) * | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New crystalline forms |
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| JP2004538268A (en) * | 2001-06-01 | 2004-12-24 | ニューロサーチ、アクティーゼルスカブ | Novel heteroaryl-diazabicycloalkanes as CNS-modulators |
| TW200418468A (en) * | 2002-11-18 | 2004-10-01 | Solvay Pharm Gmbh | Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events |
| EP1730145A1 (en) * | 2004-03-22 | 2006-12-13 | Boehringer Ingelheim Pharmaceuticals Inc. | Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics |
| SE0401539D0 (en) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| SE0401540D0 (en) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| WO2006135316A1 (en) | 2005-06-13 | 2006-12-21 | Astrazeneca Ab | New oxabispidine compounds for the treatment of cardiac arrhythmias |
| CN102485725B (en) * | 2010-12-02 | 2015-07-22 | 武汉药明康德新药开发有限公司 | Diazacyclo bridged medicine template, preparation method thereof and application thereof |
| WO2012172043A1 (en) | 2011-06-15 | 2012-12-20 | Laboratoire Biodim | Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections |
| CN102875550B (en) * | 2011-07-12 | 2016-01-06 | 常州合全药业有限公司 | 1,3,7-tri-replaces-3,7-diazabicyclos [3,3,1] nonane derivatives and preparation method |
| CN104151277A (en) * | 2014-06-30 | 2014-11-19 | 北京万全德众医药生物技术有限公司 | Preparation method of oxidation impurity dronedarone hydrochloride |
| CN113683585B (en) * | 2021-09-26 | 2023-07-11 | 齐鲁工业大学 | Preparation method of epoxy group-containing phthalonitrile monomer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2428792A1 (en) | 1974-06-14 | 1976-01-02 | Knoll Ag | NEW ANTIARRHYTHMICS |
| DE3112055A1 (en) | 1981-03-27 | 1982-10-07 | Basf Ag, 6700 Ludwigshafen | BISPIDINE DERIVATIVES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM |
| DE3234697A1 (en) | 1982-09-18 | 1984-03-22 | Kali-Chemie Pharma Gmbh, 3000 Hannover | NEW DIAZABICYCLO (3,3,1) NONANA |
| PT88381B (en) * | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | PROCESS FOR THE PREPARATION OF NEW COMPOUNDS 3,7-DIAZABICYCLO (3,3,1) NONANO, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| DE3732094A1 (en) * | 1987-09-24 | 1989-04-06 | Basf Ag | BISPID DERIVATIVES AS CLASS III ANTIARRHYTHMICS |
| US5110933A (en) | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| US5468858A (en) | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
| FR2713081B1 (en) | 1993-11-29 | 1996-01-12 | Celsa Lg | Improved blood filter with two series of petal legs. |
-
1997
- 1997-12-17 SE SE9704709A patent/SE9704709D0/en unknown
-
1998
- 1998-12-04 ZA ZA9811130A patent/ZA9811130B/en unknown
- 1998-12-10 DE DE69822513T patent/DE69822513T2/en not_active Expired - Fee Related
- 1998-12-10 HU HU0102307A patent/HUP0102307A3/en unknown
- 1998-12-10 US US09/214,756 patent/US6291475B1/en not_active Expired - Fee Related
- 1998-12-10 DK DK98962796T patent/DK1047695T3/en active
- 1998-12-10 WO PCT/SE1998/002276 patent/WO1999031100A1/en active IP Right Grant
- 1998-12-10 AU AU17953/99A patent/AU1795399A/en not_active Abandoned
- 1998-12-10 PL PL98341388A patent/PL341388A1/en unknown
- 1998-12-10 EP EP98962796A patent/EP1047695B1/en not_active Expired - Lifetime
- 1998-12-10 KR KR1020007006585A patent/KR20010024723A/en not_active Application Discontinuation
- 1998-12-10 SK SK781-2000A patent/SK7812000A3/en unknown
- 1998-12-10 BR BR9813668-2A patent/BR9813668A/en not_active IP Right Cessation
- 1998-12-10 ID IDW20001081A patent/ID24638A/en unknown
- 1998-12-10 PT PT98962796T patent/PT1047695E/en unknown
- 1998-12-10 CA CA002314490A patent/CA2314490A1/en not_active Abandoned
- 1998-12-10 CN CN98813573A patent/CN1284956A/en active Pending
- 1998-12-10 AT AT98962796T patent/ATE261964T1/en not_active IP Right Cessation
- 1998-12-10 IL IL13637498A patent/IL136374A0/en unknown
- 1998-12-10 SI SI9830633T patent/SI1047695T1/en unknown
- 1998-12-10 EE EEP200000365A patent/EE200000365A/en unknown
- 1998-12-10 NZ NZ504909A patent/NZ504909A/en unknown
- 1998-12-10 TR TR2000/01757T patent/TR200001757T2/en unknown
- 1998-12-10 ES ES98962796T patent/ES2216337T3/en not_active Expired - Lifetime
- 1998-12-10 JP JP2000539024A patent/JP2002508375A/en active Pending
- 1998-12-16 AR ARP980106399A patent/AR017217A1/en unknown
-
2000
- 2000-06-02 IS IS5522A patent/IS5522A/en unknown
- 2000-06-16 NO NO20003137A patent/NO20003137L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010024723A (en) | 2001-03-26 |
| CA2314490A1 (en) | 1999-06-24 |
| DE69822513D1 (en) | 2004-04-22 |
| DK1047695T3 (en) | 2004-06-28 |
| HUP0102307A2 (en) | 2001-12-28 |
| SE9704709D0 (en) | 1997-12-17 |
| IS5522A (en) | 2000-06-02 |
| ATE261964T1 (en) | 2004-04-15 |
| DE69822513T2 (en) | 2005-03-10 |
| NO20003137D0 (en) | 2000-06-16 |
| NZ504909A (en) | 2001-11-30 |
| ES2216337T3 (en) | 2004-10-16 |
| CN1284956A (en) | 2001-02-21 |
| SK7812000A3 (en) | 2001-05-10 |
| EE200000365A (en) | 2001-10-15 |
| PL341388A1 (en) | 2001-04-09 |
| EP1047695B1 (en) | 2004-03-17 |
| BR9813668A (en) | 2000-10-17 |
| TR200001757T2 (en) | 2000-09-21 |
| IL136374A0 (en) | 2001-06-14 |
| NO20003137L (en) | 2000-08-17 |
| HUP0102307A3 (en) | 2002-02-28 |
| JP2002508375A (en) | 2002-03-19 |
| SI1047695T1 (en) | 2004-08-31 |
| EP1047695A1 (en) | 2000-11-02 |
| WO1999031100A1 (en) | 1999-06-24 |
| ID24638A (en) | 2000-07-27 |
| PT1047695E (en) | 2004-07-30 |
| US6291475B1 (en) | 2001-09-18 |
| ZA9811130B (en) | 1999-06-17 |
| AU1795399A (en) | 1999-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR017217A1 (en) | BISPIDINE ANTIARRITHMIC COMPOUNDS, PHARMACEUTICAL FORMULATION, USE OF THE SAME TO PREPARE MEDICINES, PROCESS TO PREPARE SUCH COMPOUNDS, INTERMEDIARY COMPOUNDS, AND PROCESS TO PREPARE THEM | |
| AR037080A1 (en) | USEFUL COMPOUNDS IN THE TREATMENT OF INFLAMMATORY DISEASES, COMPOSITIONS THAT CONTAIN THEM, THEIR USE IN THERAPY, TREATMENT METHODS, PREPARATION PROCESSES AND INTERMEDIARIES | |
| DK0876366T3 (en) | Angiogenesis-inhibiting pyridazine amines | |
| RS50378B (en) | N-heterocyclic derivatives as nos inhibitors | |
| CO5290258A1 (en) | PHENILHETERO ALKYLAMINE DERIVATIVES, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | |
| HUP0202648A2 (en) | Imidazolyl derivatives, pharmaceutical compositions containing them and their use | |
| EA199800802A1 (en) | DERIVATIVES OF PYRIMIDIN-4-SHE | |
| DK0610134T3 (en) | Indole derivatives such as 5-HT, 1-like agonists | |
| AR063804A1 (en) | AZONIABICICLO COMPOUNDS [2.2.2] OCTANO | |
| AR020154A1 (en) | XICANTINE GLYCOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, USE IN THE MANUFACTURE OF MEDICINES, TREATMENT METHODS AND PREPARATION PROCESS | |
| AR002012A1 (en) | A COMPOUND, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, ITS USE, METHOD OF THERAPEUTIC TREATMENT, METHOD FOR THE PREPARATION OF THE COMPOUND. | |
| FI883669A0 (en) | 1 - / (4-PIPERIDINYL) METHYL / -1,2,3,4-TETRAHYDRO-9H-PYRIDO / 3.4-B / INDOLDERIVAT, DERAS FRAMSTAELLNING OCH TERAPEUTISKA ANVAENDNING. | |
| RS49997B (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
| AR008296A1 (en) | TETRAHYDROKINOLINE-DERIVED COMPOUNDS, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF A COMPOSITION | |
| AR046793A1 (en) | DERIVADOS DE PIRAZOL, ANTAGONISTS OF THE RECEIVER OF OREXINA | |
| DE69220133D1 (en) | N-Cyclohexyl benzamide derivatives, their preparation and therapeutic applications | |
| SE9701304D0 (en) | Compounds | |
| NO964698D0 (en) | Bicyclic amine derivatives as inhibitors of nitric oxide synthetase | |
| PE20021018A1 (en) | DERIVATIVES OF ß - CARBOLINE | |
| DK0499544T3 (en) | Use of tetrahydrothienopyridine derivatives as inhibitors of angiogenesis | |
| AR041860A1 (en) | MACROLIDO COMPOUND OF OXIMA REPLACED IN POSITION 4 '', PREPARATION PROCEDURE OF THE SAME, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | |
| DK0736012T3 (en) | Anellated dihydropyridines and their use in the preparation of pharmaceutical preparations | |
| PE35396A1 (en) | NEUROQUININE ANTAGONIST | |
| AR041720A1 (en) | DERIVATIVES OF N- BENZODIOXOLILO, N- BENZODIOXANILO AND N- BENZODIOXEPINYLARBOXAMIDE THAT CAN BE USED FOR THE TREATMENT OF DISLIPIDEMIA, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR020773A1 (en) | COMPOUND DERIVED FROM 3- (TETRAHYDROPIRIDIN-4-IL) INDOL, METHOD TO PREPARE IT, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD TO PREPARE SUCH COMPOSITION AND USE OF THE COMPOUND |